Aktiesnakken — Oktober 2010
-
now we are talking mr. Jan!!
-
-
han guider et muligt afslag?
-
(på prisen....)
-
det er ikke actionman det er actionjan....
-
må stille mig helt uforstående for hvorfor genmab ikke går 20% op på hans udtalelser....
-
og vi kan konstatere at de IKKE lægger zalu i graven....
-
Johnsen, de er ved at tage røven på aka
-
Jan om zalutumumab "for det vil vi også gerne af med"...
-
fabrik på zalut= 200 mill dollar?
-
aka - den har de allerede taget
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind